13F

Stock

Agios Pharmaceuticals, Inc.

AGIO · held by 2 managers

Reported value

$3.76M

Holders

2

+0 new · −0 exited

Holders’ est. mark

−$334.5K

Price effect on 2 books still in the name

Largest holder

$3.45M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC154.7K$3.45M−$300.1KAdded$451K
Henshaw Capital LLC13.9K$309.2K−$34.4KCut−$34.4K

Positions as of Q4 2023. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.